Healthcare Opens 35.6-Point Lead Over Tech as AI Trade Cools

Healthcare stocks have outperformed technology by 35.6 percentage points over six months, their widest lead in 25 years, according to a BeInCrypto report carried by Yahoo Finance. The divergence reflects a shift away from artificial intelligence stocks, but it also raises questions about how much further healthcare’s advantage can extend.

The report cited The Kobeissi Letter’s figures showing healthcare rising 31.7% while technology fell 3.9% over the period. Those returns describe more than a defensive sector holding up during a selloff: healthcare advanced substantially as technology lost ground, widening the difference from both directions.

The reversal was particularly pronounced against the position in early June, when technology held a 45.6-percentage-point lead, according to the report. Such a swing illustrates how quickly sector leadership can change, although a comparison of trailing returns does not establish which group will perform better next.

BeInCrypto linked the rotation to weakening confidence in the AI investment trade and a move toward drugmakers. It identified Eli Lilly, AbbVie and Johnson & Johnson among the companies driving healthcare’s gains, while describing technology selling as part of growing unease about the outlook for AI-related investment.

The first potential constraint is valuation. The report cited Morningstar as ranking healthcare the third most overvalued U.S. sector after its rally. That assessment challenges the assumption that moving away from technology necessarily means buying inexpensive stocks, particularly after a substantial increase in healthcare share prices.

The second is earnings performance. BeInCrypto pointed to disappointing October results from Johnson & Johnson as an example of how company-level developments can interrupt the broader advance. A sector attracting investors seeking alternatives to AI remains exposed to whether its businesses deliver results that justify their market valuations.

The third is a recovery in technology shares, which would reduce healthcare’s relative advantage even without a healthcare decline. The report noted a 2.5% technology rebound on November 9. A single session does not establish a lasting reversal, but it demonstrates why the gap depends on the performance of both sectors.

The divergence also matters beyond investors choosing individual healthcare or technology stocks. BeInCrypto highlighted technology’s large weighting in capitalization-weighted index funds. When sector returns differ sharply, the way an index assigns weights can influence whether a broad portfolio captures the stronger-performing area or remains more exposed to the weaker one.

The next test is whether healthcare can support its higher valuations while technology sentiment remains unsettled. The report’s three pressure points—pricing, earnings and a tech rebound—offer a framework for watching that contest, rather than evidence that a reversal is inevitable. Healthcare’s trailing lead establishes how far the rotation has progressed, not how long it will last.